https://orcid.org/0000-0001-6763-1489
References
- Grandjean P. Paracelsus revisited: the dose concept in a complex world. Basic Clin Pharmacol Toxicol. 2016 Aug;119(2):126–132. doi: 10.1111/bcpt.12622
- IATDMCT Executive Committee. Definition of TDM 2004 [cited 2023 Jul 25]. Available from: https://www.iatdmct.org/about-us/about-association/about-definitions-tdm-ct.html
- Touw DJ. Saliva for model informed precision dosing. Expert Rev Clin Pharmacol. 2023 Jun 16;1–3. doi: 10.1080/17512433.2023.2223969
- Muller IR, Linden G, Charao MF, et al. Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities. Expert Rev Clin Pharmacol. 2023 Jun;12:1–11.
- Yang L, Zhang J, Yu J, et al. Predicting plasma concentration of quetiapine in patients with depression using machine learning techniques based on real-world evidence. Expert Rev Clin Pharmacol. 2023 Jul 19;1–10. doi: 10.1080/17512433.2023.2238604
- Li D, Zhao J, Xu B, et al. Predicting busulfan exposure in patients undergoing hematopoietic stem cell transplantation using machine learning techniques. Expert Rev Clin Pharmacol. 2023 Jun;20:1–11.
- Vagrecha A, Tao V, Corless R, et al. A comprehensive strategy to address shortage of Erwinia asparaginase in pediatric acute lymphoblastic leukemia. Expert Rev Clin Pharmacol. 2023 Jun;15:1–7.
- Joynt GM, Ling L, Wong WT, et al. Therapeutic drug monitoring of carbapenem antibiotics in critically ill patients: an overview of principles, recommended dosing regimens, and clinical outcomes. Expert Rev Clin Pharmacol. 2023 Mar;27:1–12.
- Bentley S, Cheong J, Gudka N, et al. Therapeutic drug monitoring-guided dosing for pediatric cystic fibrosis patients: recent advances and future outlooks. Expert Rev Clin Pharmacol. 2023 Jul 21;1–12. doi: 10.1080/17512433.2023.2238597
- Li QY, van den Anker J, Wu YE, et al. Optimizing ganciclovir and valganciclovir dosing regimens in pediatric patients with cytomegalovirus infection: a spotlight on therapeutic drug monitoring. Expert Rev Clin Pharmacol. 2023 Feb;23:1–13.
- Penson PE, Bruckert E, Marais D, et al. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP). J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1596–1622.